Sign in
SWOG S9005: Double blind phase III randomized trial of the anti-progestin agent mifepristone in the treatment of unresectable meningioma
Journal article   Peer reviewed

SWOG S9005: Double blind phase III randomized trial of the anti-progestin agent mifepristone in the treatment of unresectable meningioma

Yongli Ji, Cathryn J Rankin, Steven M. Grunberg, Andy Sherrod, Jamshid Ahmadi, Lynn G. Feun, Ruth Fredericks, Christy Ann Russell, Fairooz F. Kabbinavar, Keith Stelzer, …
Journal of clinical oncology, Vol.33(15_suppl), pp.e17084-e17084
2015-05-20

Metrics

1 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details